Key facts
- Fourier’s last known valuation is $28.0M (Oct 2025).
- It has raised $11.3M.
- Notable investors include Tau Ventures, V12 Partners, Despierta, Innospark Ventures, Lasagna Capital — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Fourier
- ·The full record, as it builds
Funding rounds
No funding rounds for Fourier are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fourier
Developer of a medical data platform designed to summarize patient clinical data into use-case-specific insights. The company's platform brings multi-source, multi-format clinical records together to deliver thorough longitudinal summaries and clinical histories, enabling healthcare organizations to reduce administrative burden and increase revenue.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2023
- Employees
- 10
- Website
- fourierhealth.com/
- Ownership
- Privately Held (backing)
Fourier doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fourier shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fourier in its N-PORT filings yet. We sweep new filings monthly.